International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
评估艾滋病的国际流行病学数据库 (IeDEA) 南部非洲。
基本信息
- 批准号:10240757
- 负责人:
- 金额:$ 340万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAdolescentAdolescent and Young AdultAdultAdverse eventAffectAfricaAfrica South of the SaharaAfricanAnti-Retroviral AgentsBreast FeedingCOVID-19COVID-19 pandemicCaringCervical Cancer ScreeningChildClinicalCollaborationsDataData CollectionData LinkagesDatabasesDevicesDiagnosisDiagnosticDiseaseDrug resistanceDrug resistance in tuberculosisEpidemicEpidemiologyEuropeanEvaluationFundingGoalsHIVHIV SeronegativityHIV/TBHandHealthHealth ServicesHealth care facilityHealth systemHepatitis BHepatitis B VirusIncidenceIndividualInfantInfectionInternationalJointsLeadershipLife Cycle StagesLife ExpectancyLiverLung diseasesMalignant NeoplasmsMental HealthMentorshipMetabolicMethodsModelingMonitorOutcomeOutcome StudyOutputPharmaceutical PreparationsPoliciesPregnant WomenPrevalence StudyPreventionPrevention programPrevention strategyPrivate SectorPublic HealthPulmonary TuberculosisQuality of lifeRegimenRegistriesResearchResearch PersonnelResistanceRiskRisk FactorsSARS-CoV-2 transmissionSafetySentinelServicesSexually Transmitted DiseasesSouth AfricaSouth AfricanSouthern AfricaSputumStatistical ModelsSubstance Use DisorderSustainable DevelopmentTimeTranslatingTreatment outcomeTuberculosisUnited NationsUnited StatesUniversitiesViralWomanWorkWorld Health Organizationantiretroviral therapybasecancer carecancer diagnosiscancer health disparitycancer preventioncardiometabolic riskcervical cancer preventionco-infectioncohortcost effectivedata centersdata harmonizationdigitalefavirenzepidemiology studygender equitygenome sequencinghealth care settingshealth dataimplementation scienceimprovedimproved outcomein uteroinnovationlow and middle-income countriesmathematical modelmortalitynegative affectnew technologynovelopen datapoint of carepre-exposure prophylaxispreventprogramsresiliencescreeningscreening programsequencing platformsocialsubstance usetargeted sequencingtherapy durationtooltransmission processtreatment programtuberculosis drugstuberculosis treatmentuptake
项目摘要
Southern Africa is the epicenter of the HIV and tuberculosis (TB) epidemic, and South Africa is at the center of
the COVID-19 pandemic in Africa. There is an urgent need for robust epidemiology and implementation science
to address the interacting burdens of HIV, TB, and other (emerging) coinfections and non-communicable
diseases (NCDs). The International epidemiology Databases to Evaluate AIDS in Southern Africa (IeDEA-SA)
has defined six specific aims for the fourth funding period (IeDEA-SA IV): (1) to study outcomes along the
continuum of HIV care in adults; (2) to study outcomes in pregnant women, infants, children, and adolescents;
(3) to study NCDs, hepatitis B and sexually transmitted infections (STIs); (4) to study the clinical and public health
epidemiology of TB; (5) to study cancer prevention, burden, and care; and (6) to study mental health and
substance use disorders. Further, we defined six cross-cutting themes: (i) the impact of the COVID-19
pandemic on health services; (ii) gender equity; (iii) capacity building; (iv) digital transformation; (v) open science;
and (vi) the United Nations Sustainable Development Goals, which we will develop and prioritize within each
aim. Innovations include the addition of the Western Cape Provincial Health Data Centre (WC PHDC), the
South African HIV Cancer Match study, the establishment of pre-Exposure prophylaxis cohorts, and the
evaluation of novel technologies (for example, a point-of-care genome-sequencing device, a hand-held
colposcopic device for cervical cancer screening, or tools to study the transmission of TB in the health care
setting) and novel statistical and mathematical modeling approaches. Multiregional Sentinel Research
Networks (NCD-Sentinel Research Network [SRN], TB-SRN, Adolescent and Young Adult Network of
IeDEA) on NCDs, TB, and adolescents and youth will harmonize data collection across the six IeDEA regions in
low- and middle-income countries. The Fogarty-IeDEA Mentorship Program will strengthen capacity building
among early-stage investigators. IeDEA-SA now follows nearly 1.3 million people living with HIV, including
285,000 individuals from the private sector (the Aid for AIDS program AfA), and 370,000 with ART duration >
ten years. IeDEA IV will add data from 600,000 HIV-negative people through AfA and information from up to 4
million HIV-negative individuals from the WC PHDC in specific analyses. Within IeDEA, the Southern African
region includes by far the largest number of adults and children. The COVID-19 pandemic now highlights the
importance of epidemiologic research and implementation science across the health system. IeDEA-SA is well-
placed to address the specific aims and cross-cutting themes outlined in this application, through its successful
track-record of collaboration between the scientific and operational leadership at the Universities of Bern and
Cape Town, partnership with several African universities (including the Kwazulu-Natal Research Innovation
and Sequencing Platform), United States and European universities, and with the World Health Organization
and the Joint United Nations Programme on HIV/AIDS.
南部非洲是艾滋病毒和结核病流行的中心,而南非是艾滋病毒和结核病的中心。
非洲的 COVID-19 大流行。迫切需要强大的流行病学和实施科学
解决艾滋病毒、结核病和其他(新出现的)混合感染和非传染性疾病的相互作用的负担
疾病(非传染性疾病)。评估南部非洲艾滋病的国际流行病学数据库 (IeDEA-SA)
为第四个资助期 (IeDEA-SA IV) 确定了六个具体目标: (1) 研究
成人艾滋病毒护理的连续性; (2) 研究孕妇、婴儿、儿童和青少年的结果;
(3) 研究非传染性疾病、乙型肝炎和性传播感染(STI); (4)研究临床和公共卫生
结核病流行病学; (5) 研究癌症的预防、负担和护理; (6) 研究心理健康和
物质使用障碍。此外,我们定义了六个跨领域主题:(i) COVID-19 的影响
大流行对卫生服务的影响; ㈡ 性别平等; (三) 能力建设; (四) 数字化转型; (v) 开放科学;
(vi) 联合国可持续发展目标,我们将在每个目标中制定并优先考虑这些目标
目的。创新包括增加西开普省卫生数据中心 (WC PHDC)、
南非艾滋病毒癌症匹配研究、暴露前预防队列的建立以及
评估新技术(例如,床旁基因组测序设备、手持式设备)
用于宫颈癌筛查的阴道镜装置,或研究医疗保健中结核病传播的工具
设置)以及新颖的统计和数学建模方法。多区域哨点研究
网络(NCD-哨兵研究网络 [SRN]、TB-SRN、青少年和年轻人网络
关于非传染性疾病、结核病和青少年的 IeDEA)将协调 6 个 IeDEA 区域的数据收集
低收入和中等收入国家。 Fogarty-IeDEA 导师计划将加强能力建设
在早期研究人员中。 IeDEA-SA 目前正在追踪近 130 万艾滋病毒感染者,其中包括
来自私营部门的 285,000 名个人(艾滋病援助计划 AfA),以及 370,000 名接受 ART 治疗的人 >
十年。 IeDEA IV 将通过 AfA 添加 600,000 名 HIV 阴性人群的数据以及来自多达 4 个国家的信息
WC PHDC 的百万 HIV 阴性个体进行了具体分析。在 IeDEA 内,南部非洲
该地区包括迄今为止人数最多的成人和儿童。 COVID-19 大流行现在凸显了
整个卫生系统流行病学研究和实施科学的重要性。 IeDEA-SA 很好-
通过其成功的解决方案来解决本申请中概述的具体目标和跨领域主题
伯尔尼大学的科学和业务领导层之间的合作记录
开普敦,与几所非洲大学(包括夸祖鲁-纳塔尔研究创新中心)合作
和测序平台)、美国和欧洲大学以及世界卫生组织
和联合国艾滋病毒/艾滋病联合规划署。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mary-Ann Davies其他文献
Mary-Ann Davies的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mary-Ann Davies', 18)}}的其他基金
CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health)
CHERISH(儿童艾滋病毒暴露未感染研究,以告知生存和健康)
- 批准号:
10876119 - 财政年份:2020
- 资助金额:
$ 340万 - 项目类别:
CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health)
CHERISH(儿童艾滋病毒暴露未感染研究,以告知生存和健康)
- 批准号:
10064034 - 财政年份:2020
- 资助金额:
$ 340万 - 项目类别:
International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)
评估艾滋病的国际流行病学数据库 - 南部非洲 (IeDEA-SA)
- 批准号:
10090687 - 财政年份:2020
- 资助金额:
$ 340万 - 项目类别:
CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health)
CHERISH(儿童艾滋病毒暴露未感染研究,以告知生存和健康)
- 批准号:
10249343 - 财政年份:2020
- 资助金额:
$ 340万 - 项目类别:
Creating a Global fRAmework of Data collection Used for Adolescent HIV Transition Evaluation (GRADUATE)
创建用于青少年艾滋病毒过渡评估的全球数据收集框架(研究生)
- 批准号:
9321396 - 财政年份:2016
- 资助金额:
$ 340万 - 项目类别:
Closing the gaps in PMTCT program coverage, early infant diagnosis and treatment.
缩小预防母婴传播计划覆盖范围、婴儿早期诊断和治疗方面的差距。
- 批准号:
8554916 - 财政年份:2012
- 资助金额:
$ 340万 - 项目类别:
Closing the gaps in PMTCT program coverage, early infant diagnosis and treatment.
缩小预防母婴传播计划覆盖范围、婴儿早期诊断和治疗方面的差距。
- 批准号:
8434963 - 财政年份:2012
- 资助金额:
$ 340万 - 项目类别:
International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)
评估南部非洲艾滋病的国际流行病学数据库 (IeDEA-SA)
- 批准号:
8189475 - 财政年份:2006
- 资助金额:
$ 340万 - 项目类别:
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
评估艾滋病的国际流行病学数据库 (IeDEA) 南部非洲。
- 批准号:
10404615 - 财政年份:2006
- 资助金额:
$ 340万 - 项目类别:
International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)
评估南部非洲艾滋病的国际流行病学数据库 (IeDEA-SA)
- 批准号:
8299380 - 财政年份:2006
- 资助金额:
$ 340万 - 项目类别:
相似海外基金
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
- 批准号:
10684434 - 财政年份:2023
- 资助金额:
$ 340万 - 项目类别:
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
SARS-CoV-2 抗病毒核糖核苷类似物对线粒体 DNA 的影响
- 批准号:
10448062 - 财政年份:2022
- 资助金额:
$ 340万 - 项目类别:
The 24th International AIDS Conference (AIDS 2022), 29 July-2 August 2022, Montreal, Canada and virtually
第 24 届国际艾滋病大会 (AIDS 2022),2022 年 7 月 29 日至 8 月 2 日,加拿大蒙特利尔
- 批准号:
10481133 - 财政年份:2022
- 资助金额:
$ 340万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10452676 - 财政年份:2021
- 资助金额:
$ 340万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10319695 - 财政年份:2021
- 资助金额:
$ 340万 - 项目类别: